Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ADIL holding history

Adial Pharmaceuticals, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADIL overviewAll 13F holders of ADILFull Q2 2026 holdings

Shares (Q2 2026)
19,147
Value
$49.0K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of ADIL by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202619,147$49.0K<0.1%+18,605+3,432.7%AddedHolders
Q1 2026542$970<0.1%+175+47.8%AddedConverted for a 1-for-25 splitHolders
Q4 20259,167$2.02K<0.1%−9,591−51.1%ReducedHolders
Q3 202518,758$6.62K<0.1%+6,363+51.3%AddedHolders
Q2 202512,395$3.74K<0.1%−35,350−74.0%ReducedHolders
Q1 202547,745$30.3K<0.1%+26,727+127.2%AddedHolders
Q4 202421,018$21.2K<0.1%+16,614+377.2%AddedHolders
Q3 20244,404$4.40K<0.1%−79,201−94.7%ReducedHolders
Q2 202483,605$96.1K<0.1%+77,879+1,360.1%AddedHolders
Q1 20245,726$7.62K<0.1%+2,104+58.1%AddedHolders
Q4 20233,622$6.74K<0.1%+3,076+563.4%AddedHolders
Q3 2023546$1.52K<0.1%+546NewHolders
Q2 20230$00.0%−10,630−100.0%Sold outHolders
Q1 202310,630$3.72K<0.1%−11,425−51.8%ReducedHolders
Q4 202222,055$4.85K<0.1%−13,462−37.9%ReducedHolders
Q3 202235,517$12.0K<0.1%+35,517NewHolders
Q2 20220$00.0%−6,840−100.0%Sold outHolders
Q1 20226,840$14.0K<0.1%+3,216+88.7%AddedHolders
Q4 20213,624$10.0K<0.1%−766−17.4%ReducedHolders
Q3 20214,390$19.0K<0.1%+4,390NewHolders
Q2 20210$00.0%−4,447−100.0%Sold outHolders
Q1 20214,447$11.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.